Andrew Newbold

Chairman and Independent Non-Executive

Andrew is a qualified lawyer having practiced for nearly 20 years at a large commercial firm. Following his retirement from the law in 2006 he founded a renewable energy business which he sold to Origin Energy in 2009. Since that time he has been involved in a start-up property app business which he sold to ANZ in 2015 and various other businesses.

Andrew has been a director of numerous private companies and not-for-profit organizations and currently is a director of Supra Capital, a Commissioner of the AFL and a director of Golf Australia.

Joshua Fegan

Chief Executive Officer and Managing Director

Joshua is the founder of Althea Group and has extensive experience in business building, sales and marketing. He has a range of proven business and strategy skills and previously held a number of senior management roles at national value-based retailer, Strathfield Group.

Joshua founded Althea Health and Wellbeing in 2016, coinciding with registration of the ND Amendment Act, an Act to amend the ND Act, legalizing medicinal cannabis.

Gregg Battersby

Non-Executive Director

Gregg is currently Vice President of Commercial Strategy at Aphria. During his 4 year tenure at Aphria, the company has listed on the Toronto Stock Exchange, achieved a C$2.4 billion market cap and now employs in excess of 300 full time employees across Canada and Europe.

Prior to Aphria, Gregg worked with Jamieson Laboratories Ltd., a Canadian leader in natural health products and vitamins.

Alan Boyd

Independent Non-Executive Director

Alan is the Chief Financial Officer and Company Secretary of Ridley Corporation Limited, an ASX-listed provider of high performance animal nutrition solutions. Prior to this role, Alan occupied the same position with listed biotechnology companies Avexa Limited and Zenyth Therapeutics Limited, website pioneer Sausage Software Limited, and unlisted public entity HRL Limited, where he later served as a non-executive director and Chair of the Audit Committee.

Alan started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors.

Penny Dobson

Independent Non-Executive Director

Penny is an accomplished business executive in the healthcare industry. She spent nearly three decades at global pharma Merck & Co, in a variety of commercial roles across several geographies. She trained as a pharmacist in her native New Zealand, and later gained an MBA from Macquarie University.

Penny is currently Deputy Chair of the ANSTO Board, and a non-executive director at Invetus P/L.